Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial-Reference-Cited by-同舟云学术

Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial

Published:2020 Issue:4 Volume:44 Page:532
ISSN:2233-6079
Container-title:Diabetes & Metabolism Journal
language:en
Short-container-title:Diabetes Metab J

Author:

Cho Kyu Yong¹²^ORCID,Nakamura Akinobu¹,Oba-Yamamoto Chiho¹,Tsuchida Kazuhisa¹,Yanagiya Shingo¹,Manda Naoki³,Kurihara Yoshio⁴,Aoki Shin⁵,Atsumi Tatsuya¹,Miyoshi Hideaki¹⁶^ORCID

Affiliation:

1. Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

2. Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Sapporo, Japan.

3. Manda Memorial Hospital, Sapporo, Japan.

4. Kurihara Clinic, Sapporo, Japan.

5. Aoki Clinic, Sapporo, Japan.

6. Division of Diabetes and Obesity, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Publisher

Korean Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism

Link

https://e-dmj.org/pdf/10.4093/dmj.2019.0093

Reference19 articles.